Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Healthy women tend to lose more hair in July and April, and the least in February.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Consider benefits and risks of new alopecia treatments for safety.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Early treatment helps stop hair loss in women of color.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Hair microscopy is useful for diagnosing hair disorders, but clear definitions are needed for accurate genetic analysis.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Gambogic Amide helps maintain hair color and promotes hair growth.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Minoxidil absorption in skin is slowed by cleansing, depends on how long it stays on the skin, and is not much affected by reapplication.